| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.2M | +7.9% |
| Cost of Revenue | $4.9M | -11.1% |
| Gross Profit | $3.3M | +56.8% |
| R&D Expense | $10K | -28.0% |
| SG&A Expense | $3.4M | +5.4% |
| Operating Income | -$147K | +87.5% |
| Pre-tax Income | -$241K | +80.7% |
| Net Income | -$241K | +80.7% |
| EPS (Basic) | $0.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $2.1M | +3.2% |
| Current Assets | $3.0M | +10.8% |
| Total Assets | $5.8M | +20.7% |
| Current Liabilities | $2.9M | +14.3% |
| Long-term Debt | $117K | -16.4% |
| Total Liabilities | $4.2M | +31.5% |
| Stockholders' Equity | $1.6M | -0.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$293K | +21.7% |
| Capital Expenditures | $22 | -99.9% |
| Investing Cash Flow | -$22 | +99.9% |
| Financing Cash Flow | $280K | -20.3% |
| Free Cash Flow | -$293K | +27.5% |
| — |
| EPS (Diluted) | $0.00 | — |